Schizophrenia biomarkers found by GeneNews’ Sentinel Principle

A study using GeneNews’ (TSX:GEN) Sentinel Principle platform technology to identify complex changes in blood gene expression patterns that may be indicative of underlying risk factors for schizophrenia will be published in the American Journal of Medical Genetics Part B and is currently available online. “This study shows that we can identify a gene signature [...]

Enzo backs utility of GeneNews test

In an interview with partneringNews, Kevin Krenitsky, President of Enzo Clinical Labs, a unit of Enzo Biochem (NYSE:ENZ), called GeneNews’ (TSX:GEN) ColonSentry pre-screening assay for colorectal cancer risk assessment a “benchmark example for the types of tests Enzo will be advancing.” GeneNews previously licensed ColonSentry to Enzo, which submitted the test for approval to New York [...]

Prescription for growth

We, at biotuesdays.com, attended Dundee Capital Markets’ second emerging growth conference last week, where over 20 technology, life sciences and industrial growth companies presented. Dundee specializes in early-stage growth, and to say that the one-day showcase was jammed full of investment ideas is a bit of understatement. Here’s a sampling of what we took away [...]

GeneNews partner submits data to NY

Enzo Clinical Labs (NYSE: ENZ) has submitted a validation data package for GeneNews’ (TSX:GEN) ColonSentry test to New York State health regulatory authorities. “Offering first-in-class tests such as ColonSentry is a central component of Enzo’s strategy of bringing leading edge, world-class molecular tests to our customers,” Enzo Clinical Labs’ president Dr. Kevin Krenitsky said in [...]

GeneNews partner readying ColonSentry submission

Enzo Biochem’s (NYSE:ENZ) clinical labs division has completed validation testing of the GeneNews (TSX:GEN) ColonSentry pre-screening test for colorectal cancer and is in the final stages of submitting the data package to New York State regulatory authorities, according to a new report by Rodman & Renshaw. Analyst Reni Benjamin writes that the validation “demonstrated consistency [...]